ZYXI Zynex Inc

Price (delayed)

$9.38

Market cap

$298.05M

P/E Ratio

42.64

Dividend/share

N/A

EPS

$0.22

Enterprise value

$340.22M

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery ...

Highlights
Zynex's revenue has increased by 11% YoY and by 2.4% from the previous quarter
The gross profit has grown by 11% YoY and by 3% from the previous quarter
ZYXI's quick ratio is down by 30% QoQ but it is up by 15% YoY
Zynex's net income has plunged by 53% YoY and by 16% from the previous quarter
The EPS has plunged by 51% YoY and by 19% from the previous quarter

Key stats

What are the main financial stats of ZYXI
Market
Shares outstanding
31.78M
Market cap
$298.05M
Enterprise value
$340.22M
Valuations
Price to earnings (P/E)
42.64
Price to book (P/B)
9.12
Price to sales (P/S)
1.61
EV/EBIT
27.19
EV/EBITDA
18.93
EV/Sales
1.8
Earnings
Revenue
$188.68M
EBIT
$12.51M
EBITDA
$17.98M
Free cash flow
$16.76M
Per share
EPS
$0.22
Free cash flow per share
$0.52
Book value per share
$1.03
Revenue per share
$5.83
TBVPS
$3.03
Balance sheet
Total assets
$126.23M
Total liabilities
$93.13M
Debt
$75.43M
Equity
$33.1M
Working capital
$56.23M
Liquidity
Debt to equity
2.28
Current ratio
3.58
Quick ratio
2.7
Net debt/EBITDA
2.35
Margins
EBITDA margin
9.5%
Gross margin
79.7%
Net margin
4.3%
Operating margin
5.8%
Efficiency
Return on assets
5.8%
Return on equity
16.3%
Return on invested capital
10.1%
Return on capital employed
12%
Return on sales
6.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ZYXI stock price

How has the Zynex stock price performed over time
Intraday
-0.64%
1 week
7.08%
1 month
4.34%
1 year
0.75%
YTD
-13.87%
QTD
0.64%

Financial performance

How have Zynex's revenue and profit performed over time
Revenue
$188.68M
Gross profit
$150.29M
Operating income
$11.02M
Net income
$8.17M
Gross margin
79.7%
Net margin
4.3%
The net margin has plunged by 58% YoY and by 19% from the previous quarter
Zynex's operating margin has shrunk by 54% YoY
Zynex's net income has plunged by 53% YoY and by 16% from the previous quarter
The company's operating income fell by 48% YoY but it rose by 2.2% QoQ

Growth

What is Zynex's growth rate over time

Valuation

What is Zynex stock price valuation
P/E
42.64
P/B
9.12
P/S
1.61
EV/EBIT
27.19
EV/EBITDA
18.93
EV/Sales
1.8
The EPS has plunged by 51% YoY and by 19% from the previous quarter
The P/E is 25% above the last 4 quarters average of 34.2 and 3.1% above the 5-year quarterly average of 41.6
The equity has declined by 49% year-on-year and by 28% since the previous quarter
The P/B is 21% more than the last 4 quarters average of 7.6 but 6% less than the 5-year quarterly average of 9.8
The price to sales (P/S) is 64% lower than the 5-year quarterly average of 4.5 and 15% lower than the last 4 quarters average of 1.9
Zynex's revenue has increased by 11% YoY and by 2.4% from the previous quarter

Efficiency

How efficient is Zynex business performance
The ROIC has plunged by 68% YoY and by 18% from the previous quarter
ZYXI's ROA has dropped by 61% year-on-year and by 18% since the previous quarter
The ROS has contracted by 50% YoY and by 11% from the previous quarter
ZYXI's ROE is down by 37% year-on-year and by 3% since the previous quarter

Dividends

What is ZYXI's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Zynex financials performed over time
The total assets is 36% more than the total liabilities
Zynex's total liabilities has surged by 100% YoY and by 2.6% QoQ
ZYXI's quick ratio is down by 30% QoQ but it is up by 15% YoY
The debt is 128% more than the equity
The equity has declined by 49% year-on-year and by 28% since the previous quarter
Zynex's debt to equity has increased by 38% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.